Cargando…

Consumer interpretation of ramipril and clopidogrel medication risk information – implications for risk communication strategies

PURPOSE: Side effects and side-effect risk information can be provided using written medicine information. However, challenges exist in effectively communicating this information to consumers. This study aimed to explore broad consumer profiles relevant to ramipril and clopidogrel side-effect risk i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tong, Vivien, Raynor, David K, Blalock, Susan J, Aslani, Parisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501347/ https://www.ncbi.nlm.nih.gov/pubmed/26185427 http://dx.doi.org/10.2147/PPA.S86414

Ejemplares similares

Exploring consumer opinions on the presentation of side‐effects information in Australian Consumer Medicine Information leaflets
por: Tong, Vivien, et al.
Publicado: (2014)

‘It's all there in black and white’ – or is it? Consumer perspectives on the proposed Australian Medicine Information Box over‐the‐counter label format
por: Tong, Vivien, et al.
Publicado: (2015)

Enhancing provision of written medicine information in Australia: pharmacist, general practitioner and consumer perceptions of the barriers and facilitators
por: Hamrosi, Kim K, et al.
Publicado: (2014)

Ramipril in High-Risk Patients With COVID-19
por: Amat-Santos, Ignacio J., et al.
Publicado: (2020)

Opt‐in or opt‐out health‐care communication? A cross‐sectional study
por: Tong, Vivien, et al.
Publicado: (2021)

Moving from risk communication to food information communication and consumer engagement
por: Wall, Patrick G., et al.
Publicado: (2018)

Ramipril + amlodipine and ramipril + hydrochlorothiazide fixed-dose combinations in relation to patient adherence
por: Simonyi, Gábor, et al.
Publicado: (2016)

Ramipril: Angioedema: case report
Publicado: (2021)

Provision of a Medicines Information Service to Consumers on Facebook: An Australian Case Study
por: Benetoli, Arcelio, et al.
Publicado: (2015)

How do Consumers Search for and Appraise Information on Medicines on the Internet? A Qualitative Study Using Focus Groups
por: Peterson, Geraldine, et al.
Publicado: (2003)

Ramipril poisoning rescued by naloxone and terlipressin
por: Samanta, Samanta, et al.
Publicado: (2014)

Consumer opinions on adverse events associated with medicines and vaccines
por: Aslani, Parisa, et al.
Publicado: (2018)

Developing and user testing new pharmacy label formats—A study to inform labelling standards
por: Tong, Vivien, et al.
Publicado: (2021)

Mechanisms of Communicating Health Information Through Facebook: Implications for Consumer Health Information Technology Design
por: Menefee, Hannah K, et al.
Publicado: (2016)

An in-depth examination of funded and unfunded cognitive pharmaceutical services
por: Tong, Vivien, et al.
Publicado: (2021)

Incidence of Diabetes Following Ramipril or Rosiglitazone Withdrawal
Publicado: (2011)

Formulation and Evaluation of Solid Lipid Nanoparticles of Ramipril
por: Ekambaram, P, et al.
Publicado: (2011)

RP-HPLC Estimation of Ramipril and Telmisartan in Tablets
por: Kurade, V. P., et al.
Publicado: (2009)

Ramipril: Aggravation of liver toxicity: case report
Publicado: (2020)

Consumer Health-Related Activities on Social Media: Exploratory Study
por: Benetoli, Arcelio, et al.
Publicado: (2017)

Development of consumer information leaflets for deprescribing in older hospital inpatients: a mixed-methods study
por: Jokanovic, Natali, et al.
Publicado: (2019)

HIN7/440: Evidence-based Consumer Health Information - The need for unbiased risk communication
por: Hoeldke, B, et al.
Publicado: (1999)

Communicating information about “what not to do” to consumers
por: Santa, John S
Publicado: (2013)

Effect of ramipril on renal function in patients with intermittent claudication
por: Hobbs, Simon D, et al.
Publicado: (2008)

Treatment of diabetic vasculopathy with rosiglitazone and ramipril: Hype or hope?
por: Rahman, Sayeeda, et al.
Publicado: (2009)

Effect of ramipril/hydrochlorothiazide and ramipril/canrenone combination on atrial fibrillation recurrence in hypertensive type 2 diabetic patients with and without cardiac autonomic neuropathy
por: Bosone, Daniele, et al.
Publicado: (2016)

Consumer-related factors influencing antidepressant adherence in unipolar depression: a qualitative study
por: Srimongkon, Pornchanok, et al.
Publicado: (2018)

In a Subgroup of High-Risk Asians, Telmisartan Was Non-Inferior to Ramipril and Better Tolerated in the Prevention of Cardiovascular Events
por: Dans, Antonio L., et al.
Publicado: (2010)

Reducing Negative Outcomes of Online Consumer Health Information: Qualitative Interpretive Study with Clinicians, Librarians, and Consumers
por: El Sherif, Reem, et al.
Publicado: (2018)

Multiple Unit Particles System of Ramipril: An Approach to Enhance Stability
por: Patel, HP, et al.
Publicado: (2011)

Allergic reaction related to ramipril use: a case report
por: Alencar, Renata C, et al.
Publicado: (2010)

Angioedema due to fixed dose combination of telmisartan plus ramipril
por: Tandon, Vishal R., et al.
Publicado: (2014)

The effects of sacubitril/valsartan and ramipril on the male fertility in hypertensive rats
por: Aykan, Duygun Altintas, et al.
Publicado: (2020)

Ramipril Alleviates Oxaliplatin-Induced Acute Pain Syndrome in Mice
por: Bouchenaki, Hichem, et al.
Publicado: (2021)

Implication of atrial size and function in adults with repaired Tetralogy of Fallot and the effect of treatment by ramipril: the APPROPRIATE randomised trial
por: Bonello, Beatrice, et al.
Publicado: (2013)

Risk reduction with clopidogrel in the management of peripheral arterial disease
por: R Nayak, Keshav, et al.
Publicado: (2007)

The Risk of Endoscopic Mucosal Resection in the Setting of Clopidogrel Use
por: Namasivayam, Vikneswaran, et al.
Publicado: (2014)

The design and user-testing of a question prompt list for attention-deficit/hyperactivity disorder
por: Ahmed, Rana, et al.
Publicado: (2014)

The Content of COVID-19 Information Searches and Vaccination Intention: An Implication for Risk Communication
por: Olagoke, Ayokunle A., et al.
Publicado: (2022)

Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat
por: Levitt, David G, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_ri5m0l715pm8eicgghem4054t2